<DOC>
	<DOCNO>NCT02233959</DOCNO>
	<brief_summary>Prednisone solution USP ( 5mg/5mL ) , commonly prescribe formulation prednisone pediatric adult patient . The rationale study palatability important determinant pediatric patient compliance , therefore , critical Orbis formulation perceive significantly palatable compare today 's commercially available product order warrant development TP .</brief_summary>
	<brief_title>Palatability Novel Oral Formulation Prednsione</brief_title>
	<detailed_description />
	<criteria>age 18 32 year , male female healthy time study demonstrate hold 10 mL apple juice mouth 5 second without swallow expectorate content cup demonstrate ability complete study questionnaire history smoke use tobacco product previous history taste disturbance condition dietary habit know interfere sense smell taste structural functional abnormality upper gastrointestinal tract ingestion medication nutritional supplement ( exception acetaminophen tablets capsule ) 48 hour period prior study history significant illness within two week prior study history autonomic dysfunction , bronchospastic disease atopic allergy know hypersensitivity ( ie. , allergic reaction ) drug , food color agent artificial sweetener history participate clinical trial drug device within 30 day period time study brush teeth , usage mouthwash , oral ingestion substance within two hour receipt initial test article inability speak and/or read English grade 10 level</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>32 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>